Shengpeng Su

2′‐ Fucosyllactose attenuates estrogen‐deficiency‐associated bone loss and intestinal dysfunction in ovariectomized rats

Abstract BACKGROUND Postmenopausal osteoporosis (PMO), driven primarily by estrogen deficiency, is the most prevalent form of osteoporosis and a major global health burden. Estrogen deficiency disrupts gut microbial homeostasis, compromises intestinal barrier integrity and promot...